Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc, dated February 5, 2026, serves as a timing announcement for the company's full-year financial results for the period ended December 31, 2025. Smith & Nephew is a global medical technology company focused on orthopaedics, sports medicine, ENT, and advanced wound management, operating in over 100 countries.
Key Financial Metrics
The filing does not contain specific financial results for the 2025 reporting period. The only historical financial metric provided is the annual sales figure for 2024, which was $5.8 billion. No data regarding revenue, profit, cash flow, margins, debt, or liquidity for 2025 is present in this document.
Material Changes
As this document is a preliminary announcement of the reporting schedule, it does not disclose material changes in financial performance or position compared to prior periods. Investors must await the full results announcement scheduled for March 2, 2026, for comparative data.
Guidance, Outlook, and Risks
Outlook and Events: The company will announce its 2025 full-year results on Monday, March 2, 2026, at 7:00 am GMT, followed by a conference call at 8:30 am GMT. Details will be published on the company's investor website.
Risks and Contingencies: The filing includes a standard forward-looking statements disclaimer. Identified risks include:
- Geopolitical conflicts in Europe and the Middle East.
- Economic conditions affecting healthcare providers and payers.
- Regulatory approvals, reimbursement decisions, and government actions.
- Product defects, recalls, and quality management compliance.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility and changes in taxation regulations.
- Integration risks related to acquisitions and disposals.
Investor Verification Checklist
- Verify the exact timing of the earnings release and conference call on March 2, 2026.
- Confirm the 2024 baseline sales figure of $5.8 billion against upcoming 2025 results.
- Monitor the company website for the conference call dial-in details and presentation materials.
- Review the most recent Form 20-F for a detailed discussion of the risk factors listed in this filing.